The DOI matches its Crossref record; 347 of the 347 references it cites were found in a registry or an index; 9 of the 272 sources its claims cite were checked for support.
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD
Open accessAbstract
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that persists into adulthood in the majority of cases. The evidence on persistence poses several difficulties for adult psychiatry considering the lack of expertise for diagnostic assessment, limited treatment options and patient facilities across Europe. METHODS: The European Network Adult ADHD, founded in 2003, aims to increase awareness of this disorder and improve knowledge and patient care for adults with ADHD across Europe. This Consensus Statement is one of the actions taken by the European Network Adult ADHD in order to support the clinician with research evidence and clinical experience from 18 European countries in which ADHD in adults is recognised and treated. RESULTS: Besides information on the genetics and neurobiology of ADHD, three major questions are addressed in this statement: (1) What is the clinical picture of ADHD in adults? (2) How can ADHD in adults be properly diagnosed? (3) How should ADHD in adults be effectively treated? CONCLUSIONS: ADHD often presents as an impairing lifelong condition in adults, yet it is currently underdiagnosed and treated in many European countries, leading to ineffective treatment and higher costs of illness. Expertise in diagnostic assessment and treatment of ADHD in adults must increase in psychiatry. Instruments for screening and diagnosis of ADHD in adults are available and appropriate treatments exist, although more research is needed in this age group.
Overview
CoChat Summary
TL;DR
This European consensus statement concludes that ADHD often persists into adulthood, is underdiagnosed and undertreated in many European countries, and can be diagnosed with available instruments and treated with multimodal care, especially stimulants. It synthesizes expert consensus and literature to guide adult ADHD diagnosis and treatment across Europe.
Key findings
- ADHD persists into adulthood in around two-thirds of childhood cases; in a meta-analysis, about 15% retained the full diagnosis by age 25 years and a further 50% were in partial remission. Adult prevalence is estimated at 2–5%.
- In adult clinical samples, comorbidity is the rule: 75% have at least one other disorder, with a mean of three psychiatric comorbidities; around 20% of parents of children with ADHD have ADHD themselves.
- Stimulants are first-choice treatment and are effective in about 70% of patients in controlled studies; atomoxetine is second line with an effect size of around 0.4. The 6-item ASRS screener had sensitivity 68.7%, specificity 99.5%, and total classification accuracy 97.9% in population survey data, but in a substance-use-disorder sample sensitivity was 87.5% and specificity 68.6%.
- Heritability is around 76% on average in child/adolescent twin studies, while adult self-rated population twin samples report lower estimates of 30–40%; first-degree relatives have a 20–50% prevalence, and candidate gene findings explain around 3.2% of variance in children.
Methods
- Consensus statement from the European Network Adult ADHD, founded in 2003, including 40 professionals from 18 European countries; developed through three meetings between 2003 and 2009 and circulated for written approval by network members.
- Evidence was assembled from Medline, Embase, and the Cochrane Database, including reviews and randomised controlled trials in adults, reviews on ADHD in children, cross-referencing, and identification by participating experts; clinical presentation was further informed by clinical expertise.
- The statement addresses three major questions: the clinical picture of ADHD in adults, how to properly diagnose ADHD in adults, and how to effectively treat ADHD in adults.
Limitations
- The paper states that more research is needed in adults; no neurobiological or neuropsychological tests have sufficient sensitivity and specificity for individual diagnosis; psychological treatments lack an evidence base sufficient to recommend routine use; and validation of translated instruments and age-, gender-, and IQ-matched reference values are needed.
- The paper states that lower adult self-rated heritability estimates (30–40%) are not fully explained and that no empirical data resolve these questions, so further work is needed.
- Evident from the text: this is an expert consensus statement rather than a systematic review or meta-analysis, and recommendations rely on consensus and clinical experience; competing interests are disclosed for many authors.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 2 Not valid · 105 Not checked · 38 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Numerous follow-up studies of children with ADHD show that the disorder persists during adolescence and adulthood in around two-thirds of individuals [3-11] either as the full blown disorder or in 'partial remission' with persistence of some symptoms associated with continued clinical and psychosocial impairments.”
§ European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD > Background
What the sources say
- Partly supportedcites [3] Lara C, Fayyad J, de Graaf R, Kessler RC, Aguilar-Gaxiola S, Angermeyer M, Demytteneare K, de Girolamo G, Haro JM, Jin R, et al: Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol Psychiatry. 2009, 65 (1): 46-54. 10.1016/j.biopsych.2008.10.005. sourceExperimental — accuracy not yet measured
Lara et al. (2009) support substantial persistence of childhood ADHD into adulthood — the Abstract (Results) reports 'An average of 50% of children with ADHD (range: 32.8-84.1% across countries) continued to meet DSM-IV criteria for ADHD as adults,' and the Discussion repeats 'roughly 50% of childhood cases ... continue to meet full criteria.' However, the paper's own figure is ~50% (range 32.8-84.1%), not 'around two-thirds,' and its persistence outcome is full DSM-IV criteria only: no passage in our copy reports a 'partial remission' category with residual impairing symptoms (sub-threshold appears only in classifying childhood symptom profiles, Methods, 'Predictors of adult persistence'). So the two-thirds magnitude and the partial-remission-with-impairment component are not attributable to this source. (LLM, conf=0.75)
- Not checked yetcites [4] Lie N: Follow-ups of children with attention deficit hyperactivity disorder (ADHD). Review of literature. Acta Psychiatr Scand Suppl. 1992, 368: 1-40. 10.1111/j.1600-0447.1992.tb10575.x. source
- Not checked yetcites [5] Gittelman R, Mannuzza S, Shenker R, Bonagura N: Hyperactive boys almost grown up. I. Psychiatric status. Arch Gen Psychiatry. 1985, 42 (10): 937-947. source
- Not checked yetcites [6] Weiss G, Hechtman L, Milroy T: Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry. 1985, 24: 211-220. 10.1016/S0002-7138(09)60450-7. source
- Not checked yetcites [7] Mannuzza S, Klein RG, Addalli KA: Young adult mental status of hyperactive boys and their brothers: a prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1991, 30 (5): 743-751. 10.1097/00004583-199109000-00008. source
- Not checked yetcites [8] Mannuzza S, Klein RG, Bessler A, Malloy P, et al: Adult outcome of hyperactive boys: Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry. 1993, 50 (7): 565-576. source
- Not checked yetcites [9] Barkley RA, Fischer M, Smallish L, Fletcher K: The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002, 111 (2): 279-289. 10.1037/0021-843X.111.2.279. source
- Not checked yetcites [10] Mannuzza S, Klein RG, Moulton JL: Persistence of Attention-Deficit/Hyperactivity Disorder into adulthood: what have we learned from the prospective follow-up studies?. J Atten Disord. 2003, 7 (2): 93-100. 10.1177/108705470300700203. source
- Not checked yetcites [11] Rasmussen P, Gillberg C: Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. Journal of the American Academy of Child and Adolescent Psychiatry. 2000, 39 (11): 1424-1431. 10.1097/00004583-200011000-00017. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Yet, studies of self-rated ADHD symptoms in adult population twin samples consistently report lower estimates of heritability, in the region of 30-40% from two published [59,60] and one unpublished (Larsson et al., in preparation) study.”
§ European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD > Background > Genes, environment and neurobiology
What the sources say
- Not checked yetcites [59] van den Berg SM, Willemsen G, de Geus EJ, Boomsma DI: Genetic etiology of stability of attention problems in young adulthood. Am J Med Genet B Neuropsychiatr Genet. 2006, 141B (1): 55-60. 10.1002/ajmg.b.30251. source
- Supportedcites [60] Boomsma DI, Saviouk V, Hottenga JJ, Distel MA, de Moor MH, Vink JM, Geels LM, van Beek JH, Bartels M, de Geus EJ, et al: Genet epidemiol of attention deficit hyperactivity disorder (ADHD index) in adults. PloS one. 2010, 5 (5): e10621-10.1371/journal.pone.0010621. source
The Discussion reports 30% heritability for self-rated ADHD symptoms in an adult twin-family sample of over 12,000 people. It also cites a longitudinal young-adult twin study that estimated 40% heritability for self-reported attention problems, supporting the stated range. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“What is clear is that there remains a gulf in the perception of the disorder between those working in paediatric and child and adolescent mental health services and those working in adult mental health, that cannot be explained on the basis of validated evidence based information [43].”
§ European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD > Background > Stigma in general and among professionals
What the sources say
- Supportedcites [43] Asherson P, Chen W, Craddock B, Taylor E: Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry. Br J Psychiatry. 2007, 190: 4-5. 10.1192/bjp.bp.106.026484. source
The Abstract of our copy sets up exactly the contrast the citing sentence paraphrases: 'Most child and adolescent mental health services recognise the existence -and need for treatment -of a condition characterised by high levels of inattentiveness, impulsiveness and restless overactivity', with numerous specialist ADHD clinics developed, whereas 'General adult psychiatry, however, has not yet followed suit in identifying and treating substantial numbers of affected people.' The 'cannot be explained on the basis of validated evidence based information' element is carried by the VALIDITY OF THE ADULT DIAGNOSIS section, which states there are 'sufficient data and unanimous agreement among clinical experts on the validity of the adult diagnosis' and that adult ADHD symptoms show 'the same responsiveness to stimulant and non-stimulant medications as that seen in children'. The paper thus holds both that the evidence base is established and that adult services still lag, which is the gulf described; only the wording ('perception' vs. recognition/practice, and the explicit inference that evidence cannot explain it) is the citing authors'. (LLM, conf=0.82)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Although there are many challenges in identifying undiagnosed ADHD in SUD settings, systematic screening is feasible [208].”
§ European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD > How can ADHD in adults be properly diagnosed? > The assessment process
What the sources say
- Supportedcites [208] Goossensen MA, van de Glind G, Carpentier PJ, Wijsen RM, van Duin D, Kooij JJ: An intervention program for ADHD in patients with substance use disorders: preliminary results of a field trial. J Subst Abuse Treat. 2006, 30 (3): 253-259. 10.1016/j.jsat.2005.12.004. source
The Conclusion states that the protocol was feasible to implement. The Results (section 4.1) report that 928 of 1,313 admissions received ADHD screening under the protocol, supporting the claim that systematic screening is feasible in the SUD treatment settings studied. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Stimulants are effective in about 70% of patients with ADHD in controlled studies [265-267] depending on the study design and maximum drug dosage.”
§ European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD > How to treat adults with ADHD > Pharmacotherapy for adult ADHD in Europe
What the sources say
- Not checked yetcites [265] Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T: A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006, 59 (9): 829-835. 10.1016/j.biopsych.2005.09.011. source
- Partly supportedcites [266] Biederman J, Spencer T, Wilens T: Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2004, 7 (1): 77-97. 10.1017/S1461145703003973. sourceExperimental — accuracy not yet measured
The Atomoxetine section reports a 73% response rate for methylphenidate in a controlled trial of stimulant-naive children, supporting an approximately 70% figure in that group. The Stimulant drugs section also reports dose-dependent improvement, but the paper does not establish a roughly 70% response rate across all ADHD patients or say that this rate varies with study design and maximum drug dosage. Page numbers were not available in our copy. (LLM, conf=0.85)
- Not checked yetcites [267] Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, Mick E, Aleardi M, Herzig K, Faraone S: A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005, 57 (5): 456-463. 10.1016/j.biopsych.2004.11.043. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
64 more claims · 2 with their cited sources checked
Create a free account to see all 153 claims and to verify the 263 references still open.
- It may state two separate claims as one. 75
- Probably not a substantial claim. 19
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, current guidelines are inconsistent in their treatment recommendations.9, 10, 11, 12, 13, 14”
From Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis (2018) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared with childhood ADHD, adult ADHD is relatively neglected in epidemiological studies, largely due to the absence of well-established and validated diagnostic criteria [6,11,12].”
From The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis (2021) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The European Consensus Statement on Diagnosis and Treatment of Adult ADHD [71] concludes that psychostimulants are not addictive, as there is no evidence of tolerance over time, and non-compliance or cessation is a risk with stimulant medications, rather than overuse.”
From Adult ADHD and comorbid disorders: clinical implications of a dimensional approach (2017) · cites this paper as [71]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Psychostimulants, including amphetamines and methylphenidate, are first-line pharmacotherapies for individuals with attention-deficit/hyperactivity disorder (ADHD).”
The cited source says what the claim attributes to it.
In the citing paper
“The disorder can cause serious impairments for individuals in their everyday life and functioning (Kooij et al., 2010).”
From A study protocol of a randomized controlled study of internet-based cognitive behavioral therapy for adult attention deficit hyperactivity disorder (2023) · cites this paper as Kooij et al., 2010
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,651
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzem, E. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0655 · Cited by 8,477
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · cited 1×
“However, the differences in prevalence and diagnostic rates according to gender become far less skewed with age, as more females are identified and become diagnosed in adulthood [17,161,163,164]; and in some adult clinical series female cases may predominate.”
KESSLER, R. C., ADLER, L., AMES, M., DEMLER, O., FARAONE, S., HIRIPI, E., HOWES, M. J., JIN, R., SECNIK, K., SPENCER, T., et al. (2005) · Psychological Medicine · doi:10.1017/s0033291704002892 · Cited by 3,452 · cited 1×
“9%, evaluated using population survey data [216].”
Molecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357
FARAONE, S. V., BIEDERMAN, J., & MICK, E. (2006) · Psychological Medicine · doi:10.1017/s003329170500471x · Cited by 2,267 · cited 1×
“In the meta-analysis of these data from Faraone and colleagues it was concluded that about 15% retain the full diagnosis by age 25 years, with a further 50% in partial remission [12], indicating that around two-thirds of children with ADHD continue to have impairing levels of ADHD symptoms as adults.”
(1998) · Cited by 2,026
Computerized training of working memory in children with ADHD – a randomized, controlled trial
Klingberg, T., Fernell, E., Olesen, P. J., Johnson, M., Gustafsson, P., Dahlström, K., Gillberg, C. G., Forssberg, H., & Westerberg, H. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200502000-00010 · Cited by 1,949 · cited 1×
“Alternative strategies have focused on strengthening cortical (executive) function with several studies indicating treatment effects in ADHD symptoms using techniques such as working memory training and neurofeedback and cognitive remediation therapy in children [312-316] and meta-cognitive training in adults [317].”
ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation
Pappas, D. N. (2006) · Journal of Psychoeducational Assessment · doi:10.1177/0734282905285792 · Cited by 1,849 · cited 1×
“for screening include the ADHD Rating Scale, based on the DSM-IV criteria [214], and the six item World Health Organisation Adult ADHD Self-Report Scale (ASRS) Symptom Checklist (online available without limitation and in many different languages at http:// www.”
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.564 · Cited by 1,738 · cited 1×
“In childhood, as many as 65% of children with ADHD have one or more co-morbid conditions, including oppositional defiant and conduct disorder, anxiety and mood disorders, tics or Tourette syndrome, learning disorders and pervasive developmental disorders (e.g. autism) [145-147].”
Research works printed but not linked: 11
- Faraone SV, Doyle AE, Knoerzer JA: Heritability of attention-deficit/hyperactivity disorder. Economics of Neuroscience. 2001, 3 (5): 54-57.
- Kessler RC: Comorbidity patterns in a community sample of adults with ADHD: results from the National Comorbidity Survey Replication. APA 160th Annual Meeting. 2007
- Faraone SV, Sergeant J, Gillberg C: The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry. 2003, 2: 104-113.
- Murphy K, Barkley RA: Attention deficit hyperactivity disorder in adults: comorbidities and adaptive impairments. ComprPsychiatry. 1996, 37 (6): 393-401.
- Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, et al: Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007, 190: 402-409. 10.1192/bjp.bp.106.034389. · DOI · Paper page
- Nadeau KG, Quinn PO: Understanding women with AD/HD. 2002, Silver Spring: Advantage Books
- Barkley RA: Age dependent decline in ADHD: True recovery or statistical illusion?. The ADHD Report. 1997, 5: 1-5.
- Goossensen MA, van de Glind G, Carpentier PJ, Wijsen RM, van Duin D, Kooij JJ: An intervention program for ADHD in patients with substance use disorders: preliminary results of a field trial. J Subst Abuse Treat. 2006, 30 (3): 253-259. 10.1016/j.jsat.2005.12.004. · DOI · Paper page
- Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, et al: The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005, 35 (2): 245-256. 10.1017/S0033291704002892. · DOI · Paper page
- Conners CK, Erhardt D, Sparrow E: Conners Adult ADHD Rating Scales (CAARS). Technical Manual. 1999, New York: Multi Health Systems Inc
- Epstein JN, Johnson DE, Conners CK: CAADID. The Conner's Adult ADHD Diagnostic Interview for DSM-IV. 2001, MHS Inc
Cited by
Andreassen, C. S., Billieux, J., Griffiths, M. D., Kuss, D. J., Demetrovics, Z., Mazzoni, E., & Pallesen, S. (2016) · Psychology of Addictive Behaviors · doi:10.1037/adb0000160 · Cited by 2,095
“Previous research has consistently demonstrated that attentiondeficit/hyperactivity disorder (ADHD) is a risk factor for substance and behavioral addictions (Ginsberg, Quintero, Anand, Casillas, & Upadhyaya, 2014; Kooij et al., 2010).”
ResultAttention-deficit/hyperactivity disorder
Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479
Self-citationCortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30269-4 · Cited by 1,716
Song, P., Zha, M., Yang, Q., Zhang, Y., Li, X., & Rudan, I. (2021) · Journal of Global Health · doi:10.7189/jogh.11.04009 · Cited by 896
Shaw, M., Hodgkins, P., Caci, H., Young, S., Kahle, J., Woods, A. G., & Arnold, L. E. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-99 · Cited by 759
Self-citation
Metadata
- Authors
- Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., Gaillac, V., Ginsberg, Y., Henry, C., Krause, J., Lensing, M. B., Manor, I., Niederhofer, H., Nunes-Filipe, C., Ohlmeier, M. D., Oswald, P., Pallanti, S., Pehlivanidis, A., Ramos-Quiroga, J. A., Rastam, M., Ryffel-Rawak, D., Stes, S., & Asherson, P.
- Affiliations
- Karolinska Institutet (SE)
- Addenbrooke's Hospital (GB)
- Reinier van Arkel (NL)
- Uppsala University (SE)
- University of Balamand (LB)
- Trinity College Dublin (IE)
- Centre Hospitalier Charles Perrens (FR)
- Oslo University Hospital (NO)
- Tel Aviv University (IL)
- Ospedale di Bolzano (IT)
- Medizinische Hochschule Hannover (DE)
- Université Libre de Bruxelles (BE)
- University of Florence (IT)
- National and Kapodistrian University of Athens (GR)
- KU Leuven (BE)
- King's College London (GB)
- ORCID
- Venue
- BMC Psychiatry
- Published
- 2010-09-03
- Volume
- 10
- Issue
- 1
- Pages
- 67-67
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC2942810
- OpenAlex
- W2137706707
- Cited by
- 928
- References
- 336
- Citations by year
- 2026: 40 · 2025: 60 · 2024: 42 · 2023: 43 · 2022: 47 · 2021: 46 · 2020: 72 · 2019: 77 · 2018: 60 · 2017: 67 · 2016: 70 · 2015: 67 · 2014: 87 · 2013: 66 · 2012: 54
- FWCI
- 32.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- BMC Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (publishedVersion)
- Florence Research (University of Florence) (submittedVersion, other-oa)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Portal (King's College London) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
- Apollo (cc-by)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- GlaxoSmithKline
- Sanofi
- Teva Pharmaceutical Industries
- National Institute for Health and Care Research (RP-PG-0606-1045)
- Lunds Universitet
- National and Kapodistrian University of Athens
- Medizinischen Hochschule Hannover
- Universidade de Lisboa
- Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu
- H. Lundbeck A/S
- National Institutes of Health
- Medical Research Council
- Menzies Centre for Australian Studies, King's College London, University of London
- Cilag
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- adult ADHD, attention deficit hyperactivity disorder, diagnosis, treatment, clinical picture, underdiagnosis, screening tool, neurobiology, economic burden
- MeSH terms
- Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Combined Modality Therapy, Europe, Female, Humans, Male, Psychotherapy, Practice Guidelines as Topic, Disease Progression, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. https://app.cochat.ai/papers/10.1186/1471-244x-10-67
- The paper
- Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., Gaillac, V., Ginsberg, Y., Henry, C., Krause, J., Lensing, M. B., Manor, I., Niederhofer, H., Nunes-Filipe, C., Ohlmeier, M. D., . . . Asherson, P. (2010). European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. https://doi.org/10.1186/1471-244x-10-67
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.